Post-Conference Report
This post-conference report sample provides a guide to the DDR-relevant abstracts presented at the 2024 ASCO Conference, offering you a list of each abstract with information on developmental phase, target, asset, abstract summaries and more, as well as links to each. Download your free sample today.
More Resources
DDRi and ADC Combination Therapies Infographic
The 2024 DDR H1 Landscape Review
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
Speak with our Team
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
